Skip to content

    Breast Cancer Health Center

    Font Size

    Test May Help Guide Treatment of Early Breast Tumors

    Genetic Test Predicts Risk of Cancer Coming Back if Radiation Is Skipped
    WebMD Health News
    Reviewed by Laura J. Martin, MD

    Dec. 7, 2011 -- A test that categorizes very early breast cancers by their genetic fingerprint can tell a woman the likelihood that cancer may come back if she does not have radiation, researchers say.

    More than 45,000 women in the U.S. are diagnosed with this early form of breast cancer, called ductal carcinoma in situ (DCIS), each year. The tumors are confined to the milk ducts, meaning they have not invaded the rest of the breast.

    The researchers’ hope is that the test, which looks at the activity of a dozen genes from such noninvasive breast cancers, will help women with DCIS avoid unnecessary radiation.

    "Until now, we haven’t had a good way to predict which individual [noninvasive] tumors will recur," either as a new DCIS or, worse, as an invasive cancer, says researcher Lawrence Solin, MD, chairman of radiation oncology at Einstein Medical Center in Philadelphia.

    Solin presented the findings here at the San Antonio Breast Cancer Symposium. Genomic Health, which makes the test and funded the research, hopes to launch it within a few weeks.

    About Half Develop Invasive Cancer

    About half of women with DCIS will develop invasive cancer over the next few decades if nothing is done, according to Benjamin D. Smith, MD, of the University of Texas M.D. Anderson Cancer Center in Houston. Smith, who specializes in radiation treatment for women with breast cancer, was not involved with the work.

    As a result, these women are usually treated as though they have more advanced cancers -- typically with lumpectomy, followed by radiation of the breast, and sometimes hormonal drugs, he tells WebMD.

    Compared with surgery alone, radiation reduces the risk of recurrence by 50% to 60%, Smith says.

    But radiation is not without side effects. It can cause skin inflammation and make you tired. And over the long term, it can damage heart and lung tissue.

    All this points to a need for a test that can guide a discussion on whether radiation treatment can be safely skipped, Solin tells WebMD.

    Test Predicts Breast Cancer Recurrence Risk

    The new study involved 327 women with DCIS who had been treated with lumpectomy, but not radiation, as part of a previous clinical trial. Over the next decade, 26 developed invasive cancer in the same breast.

    Today on WebMD

    Breast Cancer Overview
    From mammograms to living after treatment.
    Dealing with breast cancer
    Get answers to your questions.
    woman having mammogram
    The 3 latest tips to know.
    woman undergoing breast cancer test
    Most abnormalities aren’t breast cancer.
    Resolved To Quit Smoking
    Breast Cancer Treatments Improving
    Woman getting mammogram
    Screening Tests for Women
    serious woman
    Pink badge on woman chest to support breat cancer
    what is your cancer risk
    breast cancer survivors